Cerebrovascular Disease and Statins
Elevated low-density lipoprotein-cholesterol (LDL-C) is a causal factor for the development of atherosclerotic cardiovascular disease (ASCVD); accordingly, LDL-C lowering is associated with a decreased risk of progression of atherosclerotic plaques and development of complications. Currently, statin...
Guardado en:
Autores principales: | Luis M. Beltrán Romero, Antonio J. Vallejo-Vaz, Ovidio Muñiz Grijalvo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8a3d8d1292df457a84358aad93f70458 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Loss of Hepatic Surf4 Depletes Lipid Droplets in the Adrenal Cortex but Does Not Impair Adrenal Hormone Production
por: Xiaole Chang, et al.
Publicado: (2021) -
Statins in Non-alcoholic Steatohepatitis
por: Jose D. Torres-Peña, et al.
Publicado: (2021) -
Healthcare Utilization and Statin Re‐Initiation Among Medicare Beneficiaries With a History of Myocardial Infarction
por: John N. Booth, et al.
Publicado: (2018) -
Enfermedad cerebrovascular y estatinas
por: Prat,Hernán
Publicado: (2012) -
Statin Therapy in Very Old Patients: Lights and Shadows
por: Lidia Cobos-Palacios, et al.
Publicado: (2021)